{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-166939","form_type":"8-K","ticker":"RVMD","cik":"0001628171","company_name":"Revolution Medicines, Inc.","filed_at":"2024-06-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.316495+00:00","generated_at":"2026-06-01T02:28:14.476924+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Revolution Medicines annual meeting votes approve all three proposals","bullets":["Elected Class I directors: Elizabeth McKee Anderson (107.1M for), Flavia Borellini (107.3M for), Lorence Kim (97.4M for); broker non-votes 17.7M.","Ratified PricewaterhouseCoopers as independent auditor for FY2024: 148.1M for, 9.9K against, 67.4K abstentions.","Approved non-binding advisory vote on executive compensation: 128.9M for, 1.6M against, 27K abstentions; broker non-votes 17.7M."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-166939","json":"https://secwatch.observer/filing/0001193125-24-166939.json","markdown":"https://secwatch.observer/filing/0001193125-24-166939.md","text":"https://secwatch.observer/filing/0001193125-24-166939.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628171/000119312524166939/0001193125-24-166939-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628171/000119312524166939/d853953d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:28:14.476924+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}